Ian Lorimer

Erlotinib in Lung Cancer — Molecular and Clinical Predictors of Outcome

Ming‐Sound Tsao, Akira Sakurada, Jean-Claude Cutz et al. · New England Journal of Medicine · 2005 · 1.9K citations

Medicine, Oncology, Pharmacology +14

Gefitinib Versus Placebo in Completely Resected Non–Small-Cell Lung Cancer: Results of the NCIC CTG BR19 Study

Glenwood Goss, Chris J. O’Callaghan, Ian Lorimer et al. · Journal of Clinical Oncology · 2013 · 364 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

Mark Agulnik, Ezra E.W. Cohen, Roger B. Cohen et al. · Journal of Clinical Oncology · 2007 · 263 citations · Full text

Medicine, Oncology, Pharmacology +17

Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: Targeting with a single chain antibody variable domain isolated by phage display

Ian Lorimer, Andrea Keppler‐Hafkemeyer, Richard Beers et al. · Proceedings of the National Academy of Sciences · 1996 · 135 citations · Full text

Medicine, Immunology, Oncology +15

Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic disease

Michael M. Vickers, Jair Bar, Ivan Gorn‐Hondermann et al. · Clinical & Experimental Metastasis · 2011 · 112 citations

Medicine, Molecular Biology, Oncology +17